Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
USD 26.26
(0.23%)
USD 26.26
(0.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 431 Thousand USD | -76.29% |
| 2022 | 1.81 Million USD | 3.18% |
| 2021 | 1.76 Million USD | 1879.78% |
| 2020 | 89 Thousand USD | 132.36% |
| 2019 | -275 Thousand USD | 94.73% |
| 2018 | -5.21 Million USD | 57.11% |
| 2017 | -12.16 Million USD | 21.93% |
| 2016 | -15.57 Million USD | -5.11% |
| 2015 | -14.82 Million USD | -46.07% |
| 2014 | -10.14 Million USD | -32.0% |
| 2013 | -7.68 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -6.92 Million USD | -54.13% |
| 2024 Q2 | 1.53 Million USD | 122.08% |
| 2023 Q2 | 2.35 Million USD | 94.38% |
| 2023 Q3 | 1.74 Million USD | -25.85% |
| 2023 FY | 580 Thousand USD | -68.1% |
| 2023 Q4 | -4.49 Million USD | -357.74% |
| 2023 Q1 | 1.21 Million USD | 168.05% |
| 2022 Q3 | -94 Thousand USD | -105.56% |
| 2022 Q1 | 2.1 Million USD | 230.74% |
| 2022 Q4 | -1.77 Million USD | -1791.49% |
| 2022 FY | 1.81 Million USD | 3.18% |
| 2022 Q2 | 1.69 Million USD | -19.56% |
| 2021 Q4 | -1.6 Million USD | 56.77% |
| 2021 Q2 | 4.16 Million USD | 42.92% |
| 2021 FY | 1.76 Million USD | 1879.78% |
| 2021 Q1 | 2.91 Million USD | 11.08% |
| 2021 Q3 | -3.71 Million USD | -189.16% |
| 2020 Q2 | -2.84 Million USD | -353.34% |
| 2020 Q4 | 2.62 Million USD | 64.43% |
| 2020 FY | 89 Thousand USD | 132.36% |
| 2020 Q1 | -628 Thousand USD | -164.41% |
| 2020 Q3 | 1.59 Million USD | 156.09% |
| 2019 Q3 | -358 Thousand USD | 53.32% |
| 2019 Q4 | 975 Thousand USD | 372.35% |
| 2019 Q1 | -556 Thousand USD | 63.49% |
| 2019 Q2 | -767 Thousand USD | -37.95% |
| 2019 FY | -275 Thousand USD | 94.73% |
| 2018 Q1 | -1.78 Million USD | 17.2% |
| 2018 Q4 | -1.52 Million USD | -134.67% |
| 2018 FY | -5.21 Million USD | 57.11% |
| 2018 Q2 | -624 Thousand USD | 64.96% |
| 2018 Q3 | -649 Thousand USD | -4.01% |
| 2017 Q3 | -2.76 Million USD | 8.39% |
| 2017 Q2 | -3.01 Million USD | 28.69% |
| 2017 Q1 | -4.23 Million USD | -20.61% |
| 2017 FY | -12.16 Million USD | 21.93% |
| 2017 Q4 | -2.15 Million USD | 22.18% |
| 2016 Q2 | -4 Million USD | -6.77% |
| 2016 FY | -15.57 Million USD | -5.11% |
| 2016 Q1 | -3.75 Million USD | 20.04% |
| 2016 Q4 | -3.5 Million USD | 16.36% |
| 2016 Q3 | -4.19 Million USD | -4.64% |
| 2015 Q2 | -3.48 Million USD | -11.68% |
| 2015 Q1 | -3.11 Million USD | -13.3% |
| 2015 Q4 | -4.69 Million USD | -33.04% |
| 2015 FY | -14.82 Million USD | -46.07% |
| 2015 Q3 | -3.52 Million USD | -1.38% |
| 2014 Q4 | -2.75 Million USD | -11.87% |
| 2014 Q1 | -2.33 Million USD | -23.32% |
| 2014 FY | -10.14 Million USD | -32.0% |
| 2014 Q2 | -2.6 Million USD | -11.48% |
| 2014 Q3 | -2.45 Million USD | 5.53% |
| 2013 Q3 | -2.08 Million USD | 6.32% |
| 2013 Q1 | -1.47 Million USD | 0.0% |
| 2013 Q2 | -2.23 Million USD | -51.51% |
| 2013 Q4 | -1.89 Million USD | 9.4% |
| 2013 FY | -7.68 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -13.47 Million USD | 103.198% |
| BIMI International Medical Inc. | -15.33 Million USD | 102.81% |
| China Jo-Jo Drugstores, Inc. | -3.53 Million USD | 112.194% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 580 Thousand USD | 25.69% |
| Leafly Holdings, Inc. | -7.05 Million USD | 106.113% |
| Leafly Holdings, Inc. | -7.05 Million USD | 106.113% |
| LifeMD, Inc. | -14.48 Million USD | 102.975% |
| LifeMD, Inc. | -14.48 Million USD | 102.975% |
| TRxADE HEALTH, Inc. | -7.26 Million USD | 105.934% |
| PetMed Express, Inc. | -8.16 Million USD | 105.281% |
| Walgreens Boots Alliance, Inc. | -14.07 Billion USD | 100.003% |